Adaptimmune Therapeutics Stock (NASDAQ: ADAP) stock price, news, charts, stock research, profile.
You can purchase shares of Adaptimmune Therapeutics (NASDAQ:ADAP) through any online brokerage.
Other companies in Adaptimmune Therapeutics’s space includes: Renovaro (NASDAQ:RENB), RAPT Therapeutics (NASDAQ:RAPT), Lexeo Therapeutics (NASDAQ:LXEO), Lineage Cell Therapeutics (AMEX:LCTX) and Black Diamond Therapeutic (NASDAQ:BDTX).
Adaptimmune Therapeutics has a consensus price target of $3.86.
The stock price for Adaptimmune Therapeutics (NASDAQ: ADAP) is $0.5703 last updated February 21, 2025 at 10:36 AM EST.
There are no upcoming dividends for Adaptimmune Therapeutics.
Adaptimmune Therapeutics’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
There is no upcoming split for Adaptimmune Therapeutics.
Adaptimmune Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.